Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services symbols : Apdn save search
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 1.28%
H: 21.2%
C: 18.06%
start dna agreement
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 5.0%
H: 0.02%
C: -4.76%
first year dna financial results
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
Published: 2024-02-05 (Crawled : 23:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 0.14%
H: 4.33%
C: -2.19%
first report dna financial results
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2024-01-31 (Crawled : 15:30) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -5.0%
H: 8.6%
C: 1.32%
nasdaq million direct offering dna
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -6.31%
H: 9.62%
C: 3.85%
year dna financial results
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Published: 2023-12-05 (Crawled : 16:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 2.02%
H: 7.92%
C: 2.17%
report year dna financial results
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 2.27%
H: 4.81%
C: -0.22%
diagnostic cancer dna order application
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
Published: 2023-11-16 (Crawled : 14:30) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 6.25%
H: 0.0%
C: -0.94%
dna application platform
APDN Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
Published: 2023-09-06 (Crawled : 14:00) - adnas.com
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: 4.38%
H: 2.21%
C: -3.03%
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -1.55%
H: 2.36%
C: 0.0%
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
Published: 2023-08-29 (Crawled : 20:00) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 7.09%
H: 0.0%
C: -7.35%
dna
Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
Published: 2023-08-23 (Crawled : 16:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -0.74%
H: 14.18%
C: 8.21%
patent mrna dna
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
Published: 2023-08-23 (Crawled : 15:00) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -0.74%
H: 14.18%
C: 8.21%
patent mrna
Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update
Published: 2023-08-10 (Crawled : 21:00) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -4.0%
H: 1.49%
C: -7.14%
update dna financial results
APDN to Report FQ3’23 Financial Results; Investor Conference Call/Webcast 8/10
Published: 2023-08-07 (Crawled : 16:00) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 0.61%
H: 0.3%
C: -4.88%
conference report financial
Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
Published: 2023-07-18 (Crawled : 14:20) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 0.0%
H: 0.0%
C: -3.73%
mrna dna
APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
Published: 2023-07-18 (Crawled : 14:20) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 0.0%
H: 0.0%
C: -3.73%
mrna
APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform
Published: 2023-07-13 (Crawled : 13:00) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 7.09%
H: 24.26%
C: 4.41%
platform
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach
Published: 2023-07-13 (Crawled : 12:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 7.09%
H: 24.26%
C: 4.41%
mrna reach dna platform market
APDN to Present at Upcoming Healthcare Investor Conference
Published: 2023-06-08 (Crawled : 15:20) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: -1.86%
H: 1.15%
C: -5.06%
conference
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
Published: 2023-05-11 (Crawled : 23:00) - adnas.com
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 0.0%
H: 2.78%
C: -0.93%
update dna financial results
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.